Kinin B2 receptor can play a neuroprotective role in Alzheimer's disease

Abstract Alzheimer's disease (AD) is characterized by cognitive decline, presence of amyloid-beta peptide (Aβ) aggregates and neurofibrillary tangles. Kinins act through B1 and B2 G-protein coupled receptors (B1R and B2R). Chronic infusion of Aβ peptide leads to memory impairment and increases...

Full description

Saved in:
Bibliographic Details
Published inNeuropeptides (Edinburgh) Vol. 53; pp. 51 - 62
Main Authors Caetano, A.L, Dong-Creste, K.E, Amaral, F.A, Monteiro-Silva, K.C, Pesquero, J.B, Araujo, M.S, Montor, W.R, Viel, T.A, Buck, H.S
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 01.10.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Alzheimer's disease (AD) is characterized by cognitive decline, presence of amyloid-beta peptide (Aβ) aggregates and neurofibrillary tangles. Kinins act through B1 and B2 G-protein coupled receptors (B1R and B2R). Chronic infusion of Aβ peptide leads to memory impairment and increases in densities of both kinin receptors in memory processing areas. Similar memory impairment was observed in C57BL/6 mice (WTAβ) but occurred earlier in mice lacking B2R (KOB2Aβ) and was absent in mice lacking B1R (KOB1Aβ). Thus, the aim of this study was to evaluate the participation of B1R and B2R in Aβ peptide induced cognitive deficits through the evaluation of densities of kinin receptors, synapses, cell bodies and number of Aβ deposits in brain of WTAβ, KOB1Aβ and KOB2Aβ mice. An increase in B2R density was observed in both WTAβ and KOB1Aβ in memory processing related areas. KOB1Aβ showed a decrease in neuronal density and an increase in synaptic density and, in addition, an increase in Aβ deposits in KOB2Aβ was observed. In conclusion, memory preservation in KOB1Aβ, could be due to the increase in densities of B2R, suggesting a neuroprotective role for B2R, reinforced by the increased number of Aβ plaques in KOB2Aβ. Our data point to B2R as a potential therapeutic target in AD.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0143-4179
1532-2785
DOI:10.1016/j.npep.2015.09.001